In addition to the already existing clinical development centered around rare diseases, development of oligonucleotide therapeutics for common diseases and intractable diseases such as cancer is ...

The successful application of RNA therapies to rare diseases, neurological disorders, and other conditions as well as the plethora of biopharmaceutical companies developing new RNA-based therapeutics, ...

Scientists have developed a new approach to produce life-saving oligonucleotide therapeutics on a large scale, in high purity, and with minimal environmental impacts. The finding, by The University of ...

With oligonucleotides on the rise to treat rare diseases and cancers, Japanese manufacturer Nitto Denko is laying big plans. Nitto will plug a whopping 25 billion yen ($225.93 million) into its ...

A team of biochemists at the Manchester Institute of Biotechnology has developed an isothermal biocatalytic process that can be used to manufacture therapeutic oligonucleotides in large volumes. In ...

Large-scale manufacturing of oligonucleotides could become more environmentally friendly if the biotech industry can overcome the challenges of a promising technique for synthesizing them. That’s ...

Opportunities center on integrated development-to-commercial manufacturing for complex RNA medicines, including GMP scale-up, analytical/QC, regulatory support and sterile fill-finish. Demand is ...

Scientists have developed a new approach to produce life-saving oligonucleotide therapeutics on a large scale, in high purity, and with minimal environmental impacts. Scientists have developed a new ...

Scientists have developed a new approach to produce life-saving oligonucleotide therapeutics on a large scale, in high purity, and with minimal environmental impacts. Therapeutic oligonucleotides are ...